Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,028,990
+$414,761 QoQ
Shares Held
12,037
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,646
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHEAST INVESTMENT MANAGEMENT holds $126,194,934 across 8 Drug Manufacturers - General names. ABBV ranks #5 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
54,340 | $65,177,031 | |
| 2 | JNJ |
Johnson & Johnson
|
170,118 | $43,204,868 | |
| 3 | MRK |
Merck & Co., Inc.
|
57,478 | $7,385,923 | |
| 4 | NVS |
Novartis AG
|
27,819 | $4,359,793 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
12,037 | $3,028,990 | |
| 6 | AMGN |
Amgen Inc
|
4,802 | $1,738,900 | |
| 7 | PFE |
Pfizer Inc
|
38,632 | $930,258 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,407 | $369,171 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,028,990 | 12,037 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,614,229 | 12,020 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,790,091 | 12,211 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,668,730 | 11,526 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,202,752 | 11,867 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $2,522,201 | 12,038 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,152,124 | 12,111 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $2,362,650 | 11,964 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,069,560 | 12,066 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $2,130,023 | 11,697 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,812,684 | 11,697 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,915,868 | 12,853 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,897,806 | 14,086 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,252,376 | 14,133 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $2,360,960 | 14,609 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $2,226,141 | 16,587 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $2,557,006 | 16,695 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,652,605 | 16,363 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,180,346 | 16,103 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,584,933 | 14,693 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,560,514 | 13,854 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,491,271 | 13,780 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,383,735 | 12,914 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,131,137 | 12,914 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,267,896 | 12,914 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $983,917 | 12,914 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||